For the fourth quarter of 2022 earnings season APVO decreased a loss per share of $-0.84 per share compare to $-1.28 a year ago and Income per Share improved from $-1.50 per share from the preceding reporting period.

Revenues remained unchanged to $0.00 millions from $3.67 millions in the same reporting period a year ago and sequentially Revenues surged from $0.00 millions.

Aptevo Therapeutics Inc Customers

Aptevo Therapeutics Inc growth Rates, Profitability, PE

Focusing on the fiscal time-frame closing Dec 31 2022 CADL Diminishing Returns have extended at $-0.15 per share, relative to the recent numbers of $1.54 per share a year prior reporting season, In the preceding reporting season CADL realized $-0.30 per share.

Candel Therapeutics Inc Customers

Candel Therapeutics Inc Income Statement, Balance sheets, Cash Flow Statement

In the fourth quarter of 2022 financial report Invesco Db G10 Currency Harvest Fund reached zero gain at $0.00 per share, opposite of $0.00 per share a year before reporting period, In the preceding reporting period DBV realized $0.00 per share.

Invesco Db G10 Currency Harvest Fund stock quotes, charts, profile

Invesco Db G10 Currency Harvest Fund Suppliers

As expected a 4.764%, rise in Revenues at GLXZ all along the most recent fiscal period

For the October to December 31 2022 GLXZ realized a shortfall per share of $0.00 relative to $0.02 a year prior, while Revenues advanced by 4.764 % to $5.94 millions from the comparable financial reporting period a year prior.

Galaxy Gaming Inc Customers

Galaxy Gaming Inc elevation Rates, Profitability, PE

Excellent performance by Aspira Women S Health Inc all along the October to December 31 2022 interval

For the fiscal fourth quarter of 2022 Aspira Women S Health Inc lost money of $-0.04 per share compare to $-0.08 a year before and from $-0.04 per share from the prior reporting season.

Revenues grew in double digits by 16.316 % to $2.15 millions from $1.85 millions in the similar reporting season a year before and sequentially Revenues grew by 3.909 % from $2.07 millions.

Aspira Women S Health Inc Competitors, Market Share

Aspira Women S Health Inc Income Statement, Balance sheets, Cash Flow Statement

Revenues receded by -6.343 %, at QNTO over the October to December 31 2022 time-frame

For the fourth quarter of 2022 QNTO net profit per share plummeted by -44.5 % of $0.55 per share compare to $0.99 a year ago and profit plummeted by -55.19 % from $1.22 per share from the prior financial reporting period.

Revenues decreased by -6.343 % to $8.80 millions from $9.40 millions in the similar financial reporting period a year ago and sequentially Revenues fell by -26.514 % from $11.98 millions.

Quaint Oak Bancorp Inc stock quotes, charts, profile

Quaint Oak Bancorp Inc Revenue advance Rates

EPS Drops due to Weak Sales at in the financial period ending December 31 2022

In the October to December 31 2022 the company disclosed soft top and bottom-line, where reached balanced books and revenue by -15.427 % year on year. Revenue were to $5.17 millions in proportion to $6.11 millions eps at $0.00 compared to $0.09 in the comparable three months a prior year.

Socket Mobile Inc stock quotes, charts, profile

Socket Mobile Inc Suppliers

Among many companies, the BTTX reported as well its fourth quarter of 2022 performance

The shareholders have not expected some adjustments at the business throughout the the October to December 31 2022 reporting season at the company. But, stockholders pay close attention to BTTXs' operating deficit that came in at $-8.322 millions, during the matching time.

Better Therapeutics Inc Customers

Better Therapeutics Inc growth Rates, Profitability, PE

For the fourth quarter of 2022 APVO decreased a loss per share of $-0.84 per share compare to $-1.28 a year prior and EPS improved from $-1.50 per share from the preceding financial reporting period.

Revenues remained unscathed to $0.00 millions from $3.67 millions in the comparable financial reporting period a year prior and sequentially Revenues surged from $0.00 millions.

Aptevo Therapeutics Inc Suppliers

Aptevo Therapeutics Inc Suppliers

Directing the attention towards the financial three months ending December 31 2022 CADL Diminishing Returns have widen at $-0.15 per share, relative to the recent numbers of $1.54 per share a year prior financial reporting period, In the preceding financial reporting period CADL realized $-0.30 per share.

Candel Therapeutics Inc Customers

Candel Therapeutics Inc Revenue elevation Rates

In the financial span ending December 31 2022 Invesco Db G10 Currency Harvest Fund reached balanced books at $0.00 per share, opposite of $0.00 per share a year before quarter, In the prior quarter DBV realized $0.00 per share.

Invesco Db G10 Currency Harvest Fund Suppliers

Invesco Db G10 Currency Harvest Fund rise Rates, Profitability, PE

A modest 4.764%, rise in Revenues at Galaxy Gaming Inc in the financial interval ending December 31 2022

For the financial interval ending December 31 2022 Galaxy Gaming Inc realized a shortfall per share of $0.00 relative to $0.02 a year prior, while Revenues advanced by 4.764 % to $5.94 millions from the corresponding quarter a year prior.

Galaxy Gaming Inc stock quotes, charts, profile

Galaxy Gaming Inc Income Statement, Balance sheets, Cash Flow Statement

The company announced operating shortfall in the fourth quarter of 2022

As the October to December 31 2022 reporting season continues, the most businesses have announced the respective numbers. Some of them, have been many companies in the Major Pharmaceutical Preparations industry. As well as, today, CALA announced operating shortfall of $-7.346 millions, for the fourth quarter of 2022 earnings season.

Calithera Biosciences Inc stock quotes, charts, profile

Calithera Biosciences Inc growth Rates, Profitability, PE